Full Text
The Full Text of this article is available as a PDF (59.1 KB).
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Aranda J. V., Stern L. Clinical aspects of developmental pharmacology and toxicology. Pharmacol Ther. 1983;20(1):1–51. doi: 10.1016/0163-7258(83)90044-x. [DOI] [PubMed] [Google Scholar]
- Benini F., Johnston C. C., Faucher D., Aranda J. V. Topical anesthesia during circumcision in newborn infants. JAMA. 1993 Aug 18;270(7):850–853. [PubMed] [Google Scholar]
- Cornelissen E. A., Kollée L. A., De Abreu R. A., van Baal J. M., Motohara K., Verbruggen B., Monnens L. A. Effects of oral and intramuscular vitamin K prophylaxis on vitamin K1, PIVKA-II, and clotting factors in breast fed infants. Arch Dis Child. 1992 Oct;67(10):1250–1254. doi: 10.1136/adc.67.10.1250. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Dreifuss F. E., Santilli N., Langer D. H., Sweeney K. P., Moline K. A., Menander K. B. Valproic acid hepatic fatalities: a retrospective review. Neurology. 1987 Mar;37(3):379–385. doi: 10.1212/wnl.37.3.379. [DOI] [PubMed] [Google Scholar]
- Fisher E., Siemes H., Pund R., Wittfoht W., Nau H. Valproate metabolites in serum and urine during antiepileptic therapy in children with infantile spasms: abnormal metabolite pattern associated with reversible hepatotoxicity. Epilepsia. 1992 Jan-Feb;33(1):165–171. doi: 10.1111/j.1528-1157.1992.tb02301.x. [DOI] [PubMed] [Google Scholar]
- Kearns G. L., Reed M. D. Immediate action needed to improve labeling of prescription drugs for pediatric patients. Ann Pharmacother. 1997 Feb;31(2):249–251. doi: 10.1177/106002809703100220. [DOI] [PubMed] [Google Scholar]
- Linday L. A., Ehlers K. H., O'Loughlin J. E., LaGamma E. F., Engle M. A. Noninvasive diagnosis of persistent fetal circulation versus congenital cardiovascular defects. Am J Cardiol. 1983 Oct 1;52(7):847–851. doi: 10.1016/0002-9149(83)90426-5. [DOI] [PubMed] [Google Scholar]
- Parkinson L., Hughes J., Gill A., Billingham I., Ratcliffe J., Choonara I. A randomized controlled trial of sedation in the critically ill. Paediatr Anaesth. 1997;7(5):405–410. doi: 10.1046/j.1460-9592.1997.d01-109.x. [DOI] [PubMed] [Google Scholar]
- SUTHERLAND J. M. Fatal cardiovascular collapse of infants receiving large amounts of chloramphenicol. AMA J Dis Child. 1959 Jun;97(6):761–767. doi: 10.1001/archpedi.1959.02070010763001. [DOI] [PubMed] [Google Scholar]
- Skinner J. R., Hunter S., Hey E. N. Haemodynamic features at presentation in persistent pulmonary hypertension of the newborn and outcome. Arch Dis Child Fetal Neonatal Ed. 1996 Jan;74(1):F26–F32. doi: 10.1136/fn.74.1.f26. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Starko K. M., Ray C. G., Dominguez L. B., Stromberg W. L., Woodall D. F. Reye's syndrome and salicylate use. Pediatrics. 1980 Dec;66(6):859–864. [PubMed] [Google Scholar]
- Turner S., Gill A., Nunn T., Hewitt B., Choonara I. Use of "off-label" and unlicensed drugs in paediatric intensive care unit. Lancet. 1996 Feb 24;347(9000):549–550. [PubMed] [Google Scholar]
- WEISS C. F., GLAZKO A. J., WESTON J. K. Chloramphenicol in the newborn infant. A physiologic explanation of its toxicity when given in excessive doses. N Engl J Med. 1960 Apr 21;262:787–794. doi: 10.1056/NEJM196004212621601. [DOI] [PubMed] [Google Scholar]